logo
  

TD Bank Group Q2 Profit More Than Doubles, Tops Estimates - Quick Facts

TD Bank Group (TD,TD.TO) on Thursday reported second-quarter net income of C$3.70 billion or C$1.99 per share, up sharply from C$1.52 billion or C$0.80 per share in the year-ago quarter.

Adjusted earnings for the quarter were C$2.04 per share, compared to C$0.85 per share in the prior-year quarter.

Revenue for the quarter declined to C$10.23 billion from C$10.53 billion in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of C$1.76 per share on revenues of C$10.27 billion for the quarter. Analysts' estimates typically exclude special items.

Canadian Retail reported adjusted net income for the quarter of C$2.18 billion, up 86 percent from the year-ago period. U.S. Retail recorded net income of C$1.05 billion, an increase of 292 percent compared with last year. Wholesale Banking net income surged 83 percent to C$383 million from last year.

Separately, TD Bank announced that a dividend in an amount of C$0.79 per fully paid common share in the capital stock of the Bank has been declared for the quarter ending July 31, 2021, payable on and after July 31, 2021, to shareholders of record at the close of business on July 9, 2021.

In lieu of receiving their dividends in cash, holders of the Bank's common shares may choose to have their dividends reinvested in additional common shares of the Bank in accordance with the dividend Reinvestment Plan.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT